Olema Pharmaceuticals Ownership | Who Owns Olema Pharmaceuticals?
Olema Pharmaceuticals Ownership Summary
Olema Pharmaceuticals is owned by 82.37% institutional investors, 3.31% insiders, and 14.32% retail investors. Paradigm biocapital advisors lp is the largest institutional shareholder, holding 11.48% of OLMA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.86% of its assets in Olema Pharmaceuticals shares.
OLMA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Olema Pharmaceuticals | 82.37% | 3.31% | 14.32% |
| Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
| Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Paradigm biocapital advisors lp | 6.74M | 11.48% | $25.35M |
| Bain capital life sciences investors | 6.84M | 8.00% | $29.16M |
| Blackrock | 4.00M | 7.11% | $43.27M |
| Bvf inc/il | 5.30M | 6.19% | $22.56M |
| Blackrock funding, inc. /de | 4.61M | 5.39% | $19.62M |
| Vanguard group | 2.69M | 4.69% | $15.65M |
| Deep track capital, lp | 3.44M | 4.03% | $14.67M |
| Logos global management lp | 3.21M | 3.75% | $13.67M |
| State street | 1.95M | 3.46% | $21.08M |
| Bioimpact capital | 2.38M | 2.78% | $10.13M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Bain capital life sciences investors | 6.84M | 3.65% | $29.16M |
| Ghost tree capital | 550.00K | 1.86% | $5.95M |
| Bioimpact capital | 2.38M | 1.76% | $10.13M |
| Logos global management lp | 3.21M | 1.51% | $13.67M |
| Paradigm biocapital advisors lp | 6.74M | 1.16% | $25.35M |
| Bvf inc/il | 5.30M | 0.81% | $22.56M |
| Vivo capital | 1.51M | 0.66% | $6.41M |
| Birchview capital, lp | 134.00K | 0.57% | $570.84K |
| Pier capital | 771.07K | 0.50% | $3.28M |
| Deep track capital, lp | 3.44M | 0.47% | $14.67M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 4.00M | 0.00% | 782.96K |
| Blackrock funding, inc. /de | 4.61M | 0.00% | 782.77K |
| Boxer capital | 650.00K | 0.37% | 650.00K |
| Wellington management group llp | 1.53M | 0.00% | 522.80K |
| Ubs group | 560.51K | 0.00% | 482.96K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Avoro capital advisors | - | - | -1.65M |
| Point72 asset management | - | - | -1.44M |
| State street | 1.95M | 0.00% | -1.23M |
| Polar capital | - | - | -1.00M |
| Great point partners | - | - | -1.00M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Boxer capital | 650.00K | 0.37% | 650.00K | $7.03M |
| Bnp paribas arbitrage, snc | 193.75K | 0.00% | 193.75K | $1.13M |
| Birchview capital, lp | 134.00K | 0.57% | 134.00K | $570.84K |
| Prelude capital management | 22.13K | 0.01% | 22.13K | $94.29K |
| Hsbc | 10.01K | - | 10.01K | $58.23K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -6.00 |
| Abich financial wealth management | -10.00 |
| Lindbrook capital | -41.00 |
| Srs capital advisors | -65.00 |
| Nisa investment advisors | -86.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 119 | -10.53% | 70,425,751 | 6.89% | 82 | 1.38% | 73 | 5.80% | 25 | -43.18% |
| Mar 31, 2025 | 10 | -93.71% | 26,757,361 | -62.46% | 45 | 0.29% | 5 | -94.57% | 4 | -89.19% |
| Dec 31, 2024 | 158 | 17.04% | 71,277,656 | 21.51% | 124 | 1.19% | 91 | 35.82% | 38 | -7.32% |
| Sep 30, 2024 | 135 | 4.65% | 58,661,342 | 1.34% | 102 | 0.97% | 68 | -16.05% | 41 | 28.13% |
| Jun 30, 2024 | 129 | - | 57,887,400 | 3.20% | 102 | 1.01% | 81 | 15.71% | 32 | -3.03% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 1.96M | 2.86% | -43.21K |
| Vanguard US Total Market Shares ETF | 1.49M | 2.18% | - |
| iShares Russell 2000 ETF | 1.42M | 2.08% | -26.98K |
| Franklin Biotechnology Discv A(acc)USD | 1.32M | 1.93% | - |
| Candriam Global Equities Oncology | 860.55K | 1.50% | 187.55K |
| Pictet-Biotech P USD | 931.49K | 1.36% | 11.40K |
| Franklin Small Cap Growth SMA | 917.80K | 1.34% | 917.80K |
| Franklin US Small Cap Growth Equity | 917.80K | 1.34% | 24.60K |
| Franklin Small Cap Growth Adv | 893.20K | 1.30% | - |
| Belfius Equities Cure C Cap | 850.45K | 1.24% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jan 08, 2025 | Bain Capital Life Sciences Investors, LLC | - | Buy | $1.73M |
| Dec 13, 2024 | Graham G. Walmsley | - | Buy | $4.73M |
| Dec 13, 2024 | Graham G. Walmsley | - | Sell | $4.73M |
| Dec 17, 2024 | Graham G. Walmsley | - | Sell | $4.73M |
| Dec 17, 2024 | Graham G. Walmsley | - | Sell | $4.73M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | - |
| 2025 Q1 | 1 | - |
| 2024 Q4 | 2 | 17 |
| 2024 Q3 | - | 5 |
| 2024 Q2 | - | 8 |
OLMA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools